Articles

Allogeneic stem cell transplantation benefits for patients ≥ 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Section of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Acute Leukemia Working Party of the EBMT;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
Acute Leukemia Working Party of the EBMT;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
Hematology, University Hospital, Basel, Switzerland
Center for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK
Programme de Transplantation et Thérapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, France
Daniel den Hoed Cancer Centre, Erasmus Medical Center, Rotterdam, the Netherlands
Stem Cell Transplantation Unit, HUH Comprehensive Cancer Center, Helsinki, Finland
Nottingham City Hospital, UK
Department of Hematology, Hôpital Saint-Louis, Paris, France
Service Hématologie, Centre Hospitalier Lyon Sud, France
Département d’Hématologie Clinique, CHU Lapeyronie, Montpellier, France
Département d’Hématologie, CHU Nantes, France
Deutsche Klinik für Diagnostik, KMT Zentrum, Wiesbaden, Germany
Service des Maladies du Sang, CHRU, Angers, France
Acute Leukemia Working Party of the EBMT;Service d’Hématologie, Hôpital Saint-Antoine, Paris, France
Hematology Department, IDIBAPS, Hospital Clinic, Barcelona, Spain
Acute Leukemia Working Party of the EBMT;Chaim Sheba Medical Center, Tel-Hashomer, Israel
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.178251